Stock Rich List
#2116 on the rich list of 14,452 insiders

Dinesh V. Patel, Ph.D

President and CEO at Protagonist Therapeutics. Based in Newark, California.

$64.9M
in disclosed stock, −$1.6M (−2.47%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
2116th of 14,452
Companies held
1
Largest holding
PTGX, 100.0% of total
Latest SEC filing
Sep 10, 2026

What the $64.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Protagonist Therapeutics PTGX
Common Stock
Directly522,968$124.02$64.9M100.0%Form 4, Sep 10, 2026

Share counts are the amounts Dinesh V. Patel, Ph.D reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 10, 2026SoldPTGX7,278$144.10$1.0MView
Sep 9, 2026SoldPTGX63,548$146.18$9.3MView
Sep 8, 2026SoldPTGX54,174$145.87$7.9MView
Aug 11, 2026SoldPTGX34,239$148.52$5.1MView
Aug 10, 2026SoldPTGX65,761$149.11$9.8MView
May 12, 2026SoldPTGX75,000$100.12$7.5MView
May 12, 2026SoldPTGX75,000$100.12$7.5MView
Mar 25, 2026SoldPTGX54,641$101.00$5.5MView
Mar 24, 2026SoldPTGX59$101.00$6KView
Jan 27, 2026SoldPTGX4,068$83.19$338KView
Jan 26, 2026SoldPTGX10,685$84.00$898KView
Jan 26, 2026SoldPTGX14,205$84.05$1.2MView
Jan 23, 2026SoldPTGX19,315$84.59$1.6MView
Jan 20, 2026SoldPTGX34,438$82.48$2.8MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2113Charles William Digges Jr.
Director, Central Bancompany. Jefferson City, MO
$64.9M−$1.6M (−2.36%)
2114Thomas W. Florsheim
CHAIRMAN & CEO, Weyco Group. Glendale, WI
$64.9M−$4.6M (−6.58%)
2115P. Kent Hawryluk
President & CEO, MBX Biosciences. Carmel, IN
$64.9M−$12K (−0.02%)
2116Dinesh V. Patel, Ph.D
President and CEO, Protagonist Therapeutics. Newark, CA
$64.9M−$1.6M (−2.47%)
2117Sean Michael Walters
Chief Revenue Officer, Datadog. New York, NY
$64.9M−$253K (−0.39%)
2118Mark Brazeal
Chief Legal & Corp Affairs Ofc, Broadcom. Palo Alto, CA
$64.8M−$1.4M (−2.09%)
2119Paul Badawi
President and CEO, Sight Sciences. Menlo Park, CA
$64.7M−$914K (−1.39%)

Other Protagonist Therapeutics insiders

All PTGX insiders

Questions

How much stock does Dinesh V. Patel, Ph.D own?

Dinesh V. Patel, Ph.D holds $64,858,491 in listed stock based on SEC filings and current prices, mostly Protagonist Therapeutics (PTGX). That ranks 2116th on the Stock Rich List.

Is this Dinesh V. Patel, Ph.D's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Dinesh V. Patel, Ph.D last buy or sell stock?

The most recent open-market trade on file is a sale of 7,278 PTGX shares on Sep 10, 2026 at $144.10.